Interparfums, Inc. reports Q2 2025 results, highlighting a slight sales decline, improved gross margins, and ongoing market challenges.
Quiver AI Summary
Interparfums, Inc. reported its financial results for the second quarter and first half of 2025, revealing a 2% decline in net sales for the quarter compared to the previous year, although year-to-date sales increased by 1%. Gross margins improved, reaching 66.2% for the second quarter, while operating income decreased by 9%. The company experienced a 13% drop in net income and diluted earnings per share compared to the same period in 2024. Positive performance was seen in North America and Western Europe, while sales in Asia-Pacific declined notably due to prior-year highs and current distribution issues. Interparfums signed a global licensing agreement with Longchamp, adding to its brand portfolio, and they plan to continue investing in their brands and adapting to market conditions. The company reaffirmed its guidance for the year, aiming for $1.51 billion in net sales and earnings per share of $5.35 while also declaring a quarterly dividend of $0.80 per share.
Potential Positives
- Despite a slight decrease in net sales for the second quarter, the year-to-date sales increased by 1%, demonstrating overall growth for the first half of 2025.
- The company expanded its gross margin by 170 bps to 66.2% in the second quarter and 150 bps to 65.0% for the first half, indicating improved profitability from sales.
- Interparfums' strong cash position is highlighted by $205 million in cash and cash equivalents, supporting financial stability for future investments.
- The signing of an exclusive global license agreement with Longchamp, adding to a growing portfolio that now includes Off-White and Goutal, positions the company for future growth and brand diversification.
Potential Negatives
- Net sales for the second quarter decreased by 2% compared to the previous year, indicating potential challenges in maintaining revenue growth.
- Operating income and net income both saw significant declines of 9% and 13%, respectively, compared to the prior year, raising concerns about the company's profitability.
- SG&A expenses as a percentage of net sales increased, suggesting rising costs that could impact future earnings.
FAQ
What were Interparfums' financial highlights for Q2 2025?
Interparfums reported net sales of $334 million, with a gross margin of 66.2% and net income of $32 million.
How did foreign exchange rates impact Interparfums' sales?
The dollar/euro exchange rate had a positive impact of 2.0% on net sales for Q2 2025.
What are the sales trends in different regions for Interparfums?
North America and Western Europe saw 7% and 3% sales growth, while Asia-Pacific sales decreased by 12% in H1 2025.
What is Interparfums' outlook for the second half of 2025?
The company is cautiously optimistic, reaffirming guidance for $1.51 billion in net sales and $5.35 earnings per share.
When will Interparfums pay its next dividend?
A quarterly cash dividend of $0.80 per share will be paid on September 30, 2025, to shareholders recorded by September 15, 2025.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$IPAR Insider Trading Activity
$IPAR insiders have traded $IPAR stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $IPAR stock by insiders over the last 6 months:
- PHILIPPE BENACIN (President Interparfums SA) sold 25,000 shares for an estimated $2,934,602
- JEAN MADAR (CEO) sold 13,000 shares for an estimated $1,679,204
- PHILIPPE SANTI (Exec VP Interparfums SA) has made 0 purchases and 3 sales selling 2,000 shares for an estimated $278,509.
- VERONIQUE GABAI-PINSKY sold 1,500 shares for an estimated $183,222
- GILBERT HARRISON sold 400 shares for an estimated $53,584
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IPAR Hedge Fund Activity
We have seen 150 institutional investors add shares of $IPAR stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP added 554,554 shares (+7724.7%) to their portfolio in Q1 2025, for an estimated $63,147,063
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 500,378 shares (+251.4%) to their portfolio in Q1 2025, for an estimated $56,978,042
- AMERICAN CENTURY COMPANIES INC removed 381,165 shares (-84.0%) from their portfolio in Q1 2025, for an estimated $43,403,258
- PARALEL ADVISORS LLC removed 290,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $38,079,900
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 228,339 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $29,983,194
- VICTORY CAPITAL MANAGEMENT INC added 151,358 shares (+26.9%) to their portfolio in Q1 2025, for an estimated $17,235,135
- ANNEX ADVISORY SERVICES, LLC removed 150,567 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $19,770,952
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IPAR Analyst Ratings
Wall Street analysts have issued reports on $IPAR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BWS Financial issued a "Buy" rating on 05/07/2025
- Piper Sandler issued a "Overweight" rating on 04/24/2025
- DA Davidson issued a "Buy" rating on 03/25/2025
- Canaccord Genuity issued a "Buy" rating on 02/27/2025
To track analyst ratings and price targets for $IPAR, check out Quiver Quantitative's $IPAR forecast page.
$IPAR Price Targets
Multiple analysts have issued price targets for $IPAR recently. We have seen 4 analysts offer price targets for $IPAR in the last 6 months, with a median target of $169.0.
Here are some recent targets:
- Hamed Khorsand from BWS Financial set a target price of $172.0 on 05/07/2025
- Korinne Wolfmeyer from Piper Sandler set a target price of $138.0 on 04/24/2025
- Linda Bolton Weiser from DA Davidson set a target price of $170.0 on 03/25/2025
- Susan Anderson from Canaccord Genuity set a target price of $168.0 on 02/27/2025
Full Release
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the second quarter and six months ended June 30, 2025.
Financial Highlights:
($ in millions, except per share amounts) |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||
2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||
Net Sales | $334 | $342 | (2%) | $673 | $666 | +1% | ||||||||||
Gross Margin | 66.2% | 64.5% | +170 bps | 65.0% | 63.5% | +150 bps | ||||||||||
Operating Income | $59 | $65 | (9%) | $134 | $133 | +1% | ||||||||||
Operating Margin | 17.7% | 18.9% | (120) bps | 20.0% | 19.9% | +10 bps | ||||||||||
Net Income attributable to Interparfums, Inc. | $32 | $37 | (13%) | $74 | $78 | (4%) | ||||||||||
Diluted EPS | $0.99 | $1.14 | (13%) | $2.32 | $2.41 | (4%) | ||||||||||
The average dollar/euro exchange rate for the 2025 second quarter was 1.13 compared to 1.08 in the 2024 second quarter, while for the first six months of 2025, the average dollar/euro exchange rate was 1.09 compared to 1.08 in the first six months of 2024, leading to a positive 2.0% and 0.4% foreign exchange impact on net sales for the second quarter and first six months of 2025, respectively. |
Operational Commentary
Jean Madar, Chairman & Chief Executive Officer of Interparfums, noted, “Demand in the United States, which accounted for 35% of our second quarter net sales, remains strong, even as growth in the global fragrance market has begun to ease off. We are confident in our ability to navigate this environment thanks to the strength of our brand portfolio and our global network of distributors and retail partners, which give us access to a wide range of consumers across markets. While second quarter results were affected, and we anticipate that some of these headwinds will persist into the second half of the year, our proactive and timely actions position us to fully resolve these challenges in 2026.
“Our two largest markets, North America and Western Europe, grew sales by 7% and 3% on a year-to-date basis. Asia-Pacific fragrance sales were down 12% for the first half, with the decline primarily due to last year’s exceptional sales in Australia and distribution disruptions in South Korea in the current year while the overall trend remains positive in China and Japan.
“Central & South America sales increased 7% during the first six months, propelled by the strong performance of Lacoste fragrances and healthy market growth. Sales in Eastern Europe were up 14% as compared to the first half of 2024, where we faced temporary sourcing constraints. The Middle East & Africa declined 19%, primarily due to a disproportionate impact from the exit of the Dunhill license; excluding the impact of Dunhill, net sales declined 6% due to conflict in the region and as more doors focused on higher end luxury fragrances.
“As announced last month, we signed an exclusive global license agreement with Longchamp, further strengthening our portfolio. This marks the third new brand we have added to our portfolio since December 2024, preceded by Off-White and Goutal. Additionally, our first owned brand fragrance collection, Solférino, remains on track with a highly selective distribution and elevated merchandising strategy as we prepare to open our flagship Paris boutique next month.
Mr. Madar concluded, “As always, we remain committed to investing in our brands and capabilities while maintaining the flexibility to adapt to evolving market conditions. Although the imposition of tariffs and a dynamic market environment may present near-term challenges due to trade destocking, our recent pricing strategies, upcoming fragrance launches, and foreign exchange tailwinds are expected to be the catalysts in driving stronger results in the second half of 2025 leading to continued market share gains.”
Financial Commentary
Michel Atwood, Chief Financial Officer of Interparfums, noted, “Consolidated gross margin expanded 170 bps to 66.2% and 150 bps to 65.0% in the second quarter and first half of 2025, respectively, as a result of favorable segment and brand mix.
“SG&A expenses as a percentage of net sales were 48.5% and 45.0% for the second quarter and first half of 2025 as compared to 45.6% and 43.6% for the comparable periods in 2024, attributable to higher levels of advertising and promotional expenditures in 2025. These expenditures represented 20.6% and 17.9% of net sales for the second quarter and first half of 2025, compared to 19.4% and 17.2% for the respective periods of the prior year.
“The key metrics mentioned resulted in operating margins aggregating 17.7% and 20.0% for the second quarter and first half of 2025, respectively, as compared to 18.9% and 19.9% for the corresponding periods of 2024.
“Below the operating line, first half net income was unfavorably impacted by other expenses of $6.7 million compared to $1.5 million in last year’s first half. Through June 30, 2025, we recorded $2.4 million in losses on foreign currency and a $3.4 million loss on marketable securities, while in the same period last year, there was a foreign currency gain of $0.3 million and a loss of $0.6 million on marketable securities.
“These factors contributed to our second quarter net income of $32 million, or $0.99 per diluted share.
“Our financial position remains healthy with $205 million in cash, cash equivalents and short-term investments, and working capital of $654 million. In the first half of 2025, we improved our operating cash flow by $31 million compared to the same period last year, shifting from $26 million of cash consumption to $5 million of cash generation as our inventory initiatives began to deliver results.”
Reaffirms 2025 Guidance
Mr. Atwood concluded, “Despite healthy sellout in the first half driven by the strength of our portfolio and disciplined execution, our sales were slightly below expectations due to continued trade destocking. As we look ahead to the second half, we remain mindful of the ongoing macroeconomic uncertainty, including tariff-related supply chain impacts, moderating demand in several international markets outside the United States, and continued volatility of the EUR/USD exchange rate.
“Nevertheless, we are cautiously optimistic in our ability to achieve the full year objectives we initially laid out in November 2024, supported by the continued resilience of the fragrance category, tariff induced second half pricing actions, and continuing foreign exchange tailwinds. As such, we are reaffirming our 2025 guidance, which calls for net sales of $1.51 billion and earnings per diluted share of $5.35.”
Dividend
The Company’s regular quarterly cash dividend of $0.80 per share will be paid on September 30, 2025, to shareholders of record on September 15, 2025.
Conference Call
Management will host a conference call to discuss financial results and business operations beginning at 11:00 am ET on Wednesday, August 6, 2025.
Interested parties may participate in the live call by dialing:
U.S. / Toll-free: (877) 423-9820
International: (201) 493-6749
Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin.
A live audio webcast will also be available in the “Events” tab within the Investor Relations section of the Company’s website at www.interparfumsinc.com , or by clicking here . The conference call will be available for webcast replay for approximately 90 days following the live event.
About Interparfums, Inc.:
Operating in the global fragrance business since 1982, Interparfums, Inc. produces and distributes a wide array of prestige fragrance and fragrance related products under license and other agreements with brand owners. The Company manages its business in two operating segments, European based operations, through its 72% owned subsidiary, Interparfums SA, and United States based operations, through wholly owned subsidiaries in the United States and Italy.
Our portfolio of prestige brands includes Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Longchamp, MCM, Moncler, Montblanc, Oscar de la Renta, Roberto Cavalli, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world through an extensive and diverse network of distributors. Interparfums, Inc. is also the registered owner of several trademarks including Lanvin, Rochas, and Solférino. Goutal and Off-White will join the Company’s fragrance portfolio in 2026.
Forward-Looking Statements
Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as "anticipate, "believe", "could", "estimate", "expect", "intend", "may", "should", "will", and "would" or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Interparfums' annual report on Form 10-K for the fiscal year ended December 31, 2024, and the reports Interparfums files from time to time with the Securities and Exchange Commission. Interparfums does not intend to and undertakes no duty to update the information contained in this press release.
Contact Information:
Interparfums, Inc.
Michel Atwood Chief Financial Officer (212) 983-2640 www.interparfumsinc.com |
or |
The Equity Group Inc.
Karin Daly Investor Relations Counsel (212) 836-9623 / [email protected] www.theequitygroup.com |
See Accompanying Tables | |||||||||
INTERPARFUMS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (In thousands except share and per share data) (Unaudited) |
|||||||||
ASSETS | |||||||||
June 30,
2025 |
December 31,
2024 |
||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 151,454 | $ | 125,433 | |||||
Short-term investments | 53,901 | 109,311 | |||||||
Accounts receivable, net | 296,043 | 274,705 | |||||||
Inventories | 425,349 | 371,920 | |||||||
Receivables, other | 8,133 | 6,122 | |||||||
Other current assets | 50,083 | 27,035 | |||||||
Income taxes receivable | 2,024 | 306 | |||||||
Total current assets | 986,987 | 914,832 | |||||||
Property, equipment and leasehold improvements, net | 185,356 | 153,773 | |||||||
Right-of-use assets, net | 23,328 | 24,603 | |||||||
Trademarks, licenses and other intangible assets, net | 333,353 | 282,484 | |||||||
Deferred tax assets | 12,618 | 17,034 | |||||||
Other assets | 20,106 | 18,535 | |||||||
Total assets | $ | 1,561,748 | $ | 1,411,261 | |||||
LIABILITIES AND EQUITY | |||||||||
Current liabilities: | |||||||||
Loans payable - banks | $ | 44,536 | $ | 8,311 | |||||
Current portion of long-term debt | 56,745 | 41,607 | |||||||
Current portion of lease liabilities | 6,250 | 6,087 | |||||||
Accounts payable – trade | 93,146 | 91,049 | |||||||
Accrued expenses | 126,753 | 172,758 | |||||||
Income taxes payable | 5,571 | 12,615 | |||||||
Total current liabilities | 333,001 | 332,427 | |||||||
Long–term debt, less current portion | 153,112 | 115,734 | |||||||
Lease liabilities, less current portion | 18,883 | 20,455 | |||||||
Equity: | |||||||||
Interparfums, Inc. shareholders’ equity: | |||||||||
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued | — | — | |||||||
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,117,600 and 32,110,170 shares at June 30, 2025 and December 31, 2024, respectively | 32 | 32 | |||||||
Additional paid-in capital | 108,802 | 106,702 | |||||||
Retained earnings | 787,031 | 763,240 | |||||||
Accumulated other comprehensive loss | (1,599 | ) | (72,239 | ) | |||||
Treasury stock, at cost, 10,001,665 and 9,981,665 shares at June 30, 2025 and December 31, 2024, respectively | (54,907 | ) | (52,864 | ) | |||||
Total Interparfums, Inc. shareholders’ equity | 839,359 | 744,871 | |||||||
Noncontrolling interest | 217,393 | 197,774 | |||||||
Total equity | 1,056,752 | 942,645 | |||||||
Total liabilities and equity | $ | 1,561,748 | $ | 1,411,261 | |||||
INTERPARFUMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (In thousands except per share data) (Unaudited) |
||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net sales | $ | 333,936 | $ | 342,229 | $ | 672,755 | $ | 666,192 | ||||||||
Cost of sales | 112,847 | 121,472 | 235,689 | 243,050 | ||||||||||||
Gross margin | 221,089 | 220,757 | 437,066 | 423,142 | ||||||||||||
Selling, general and administrative expenses | 161,913 | 155,929 | 302,813 | 290,341 | ||||||||||||
Income from operations | 59,176 | 64,828 | 134,253 | 132,801 | ||||||||||||
Other expenses (income): | ||||||||||||||||
Interest expense | 1,787 | 1,941 | 3,332 | 3,748 | ||||||||||||
Loss (gain) on foreign currency | 1,580 | 634 | 2,360 | (270 | ) | |||||||||||
Interest and investment loss (income) | 1,929 | 1,076 | 1,349 | (1,944 | ) | |||||||||||
Other income | (245 | ) | (74 | ) | (324 | ) | (37 | ) | ||||||||
5,051 | 3,577 | 6,717 | 1,497 | |||||||||||||
Income before income taxes | 54,125 | 61,251 | 127,536 | 131,304 | ||||||||||||
Income taxes | 12,928 | 14,653 | 30,936 | 31,403 | ||||||||||||
Net income | 41,197 | 46,598 | 96,600 | 99,901 | ||||||||||||
Less: Net income attributable to the noncontrolling interest | 9,209 | 9,775 | 22,120 | 22,030 | ||||||||||||
Net income attributable to Interparfums, Inc. | $ | 31,988 | $ | 36,823 | $ | 74,480 | $ | 77,871 | ||||||||
Earnings per share: | ||||||||||||||||
Net income attributable to Interparfums, Inc. common shareholders: | ||||||||||||||||
Basic | $ | 1.00 | $ | 1.15 | $ | 2.32 | $ | 2.43 | ||||||||
Diluted | $ | 0.99 | $ | 1.14 | $ | 2.32 | $ | 2.41 | ||||||||
Weighted average number of shares outstanding: | ||||||||||||||||
Basic | 32,110 | 32,024 | 32,115 | 32,033 | ||||||||||||
Diluted | 32,149 | 32,266 | 32,162 | 32,266 | ||||||||||||
Dividends declared per share | $ | 0.80 | $ | 0.75 | $ | 1.60 | $ | 1.50 |